Zobrazeno 1 - 10
of 151
pro vyhledávání: '"HER2, human epidermal growth factor receptor 2"'
Autor:
Nan Hu, Jun Feng Yin, Ze Ji, Yidong Hong, Puyuan Wu, Baoxiang Bian, Ziyan Song, Rutian Li, Qin Liu, Fenglei Wu
Publikováno v:
Cellular Physiology and Biochemistry, Vol 44, Iss 6, Pp 2158-2173 (2017)
Background/Aims: MicroRNA-21 is an oncogenic miR (oncomiR) frequently elevated in gastric cancer (GC). Overexpression of miR-21 decreases the sensitivity of GC cells to 5-fluorouridine (5-Fu) and trastuzumab, a humanized monoclonal antibody targeting
Externí odkaz:
https://doaj.org/article/9b93d064444f46628a91b7f145a25bf8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Rugo, Hope S., Lacouture, Mario E., Goncalves, Marcus D., Masharani, Umesh, Aapro, Matti S., O'Shaughnessy, Joyce A.
Publikováno v:
Breast, Vol 61, Iss, Pp 156-167 (2022)
The Breast : Official Journal of the European Society of Mastology
The Breast : Official Journal of the European Society of Mastology
Purpose The oral, α-specific phosphatidylinositol-3-kinase (PI3Kα) inhibitor alpelisib is the first PI3K inhibitor approved for the treatment of advanced breast cancer. As alpelisib is a relatively new therapeutic option, specific guidance and a mu
Autor:
Elizabeth W. Thompson, Biniyam G. Demissei, Amanda M. Smith, Priya Brahmbhatt, Jessica Wang, Amy Clark, Angela DeMichele, Vivek Narayan, Payal Shah, Lova Sun, Benedicte Lefebvre, Michael G. Fradley, Joseph R. Carver, W.H. Wilson Tang, Bonnie Ky
Publikováno v:
JACC: Basic to Translational Science
Visual Abstract
Highlights • PON-1 is an HDL-associated cardioprotective enzyme that prevents oxidized-LDL formation and has not previously been studied in cardio-oncology. • To determine the associations between PON-1 and the development of
Highlights • PON-1 is an HDL-associated cardioprotective enzyme that prevents oxidized-LDL formation and has not previously been studied in cardio-oncology. • To determine the associations between PON-1 and the development of
Autor:
Alexander Hapfelmeier, Sebastian Foersch, Siranush Karapetyan, Daniel-Christoph Wagner, Katja Steiger, Kristina Schwamborn, Marion Kiechle, Wilko Weichert, Wilfried Roth, Dirk Oettler, Aurelia Noske
Publikováno v:
Breast, Vol 60, Iss, Pp 238-244 (2021)
The Breast : Official Journal of the European Society of Mastology
The Breast : Official Journal of the European Society of Mastology
Different immunohistochemical programmed death-ligand 1 (PD-L1) assays and scorings have been reported to yield variable results in triple-negative breast cancer (TNBC). We compared the analytical concordance and reproducibility of four clinically re
Publikováno v:
Acta Pharmaceutica Sinica. B
Acta Pharmaceutica Sinica B, Vol 11, Iss 11, Pp 3417-3432 (2021)
Acta Pharmaceutica Sinica B, Vol 11, Iss 11, Pp 3417-3432 (2021)
Compounds that selectively modulate multiple targets can provide clinical benefits and are an alternative to traditional highly selective agents for unique targets. High-throughput screening (HTS) for multitarget-directed ligands (MTDLs) using approv
Autor:
Eleonora De Maio, Gabrielle Selmes, Slimane Zerdoud, Eva Jouve, R. Aziza, Jean-Louis Lacaze, Ciprian Chira, F. Izar, Florence Dalenc, C. Massabeau, Mony Ung, Anne Pradines
Publikováno v:
Breast, Vol 59, Iss, Pp 144-156 (2021)
The Breast : Official Journal of the European Society of Mastology
The Breast : Official Journal of the European Society of Mastology
Does oligometastatic breast cancer (OMBC) deserve a dedicated treatment? Although some authors recommend multidisciplinary management of OMBC with a curative intent, there is no evidence proving this strategy beneficial in the absence of a randomized
Autor:
Kenth Gustafsson, Rana Khalife, Konstantin Pildish, Rupali Dabas, Sofia Esteban Serna, Vladimir Kalinovskiy, Noelle Colant, Matas Deveikis, Alexander Van de Steen, Saverio Charalambous, Hasan Mustafa Khan, Stefanie Frank, Clare M. Robinson, Diana A. Catana
Publikováno v:
Synthetic and Systems Biotechnology, Vol 6, Iss 3, Pp 231-241 (2021)
Synthetic and Systems Biotechnology
Synthetic and Systems Biotechnology
The development of Drug Delivery Systems (DDS) has led to increasingly efficient therapies for the treatment and detection of various diseases. DDS use a range of nanoscale delivery platforms produced from polymeric of inorganic materials, such as mi
Autor:
Rosell Murillo, Marina
Als hospitals Vall d'Hebron i Bellvitge s'utilitzen dues marques diferents de tinció de cèl·lules HER2 per diagnosticar pacients amb càncer de mama HER2 positiu, que presenten variacions de color. Disposem d'un conjunt de dades etiquetades de Val
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3484::dba86a4e90a7d79dc63702a7e147dbad
https://hdl.handle.net/2117/380696
https://hdl.handle.net/2117/380696
Bilateral breast metastases from small cell lung carcinoma: Case report and review of the literature
Autor:
Emad Allam, Luke Freiburg, John Olivieri, Vijayalakshmi Ananthanarayanan, Shuchi Zinzuwadia, Cheryl Zhang
Publikováno v:
Radiology Case Reports, Vol 16, Iss 7, Pp 1718-1726 (2021)
Radiology Case Reports
Radiology Case Reports
Differentiation of primary versus secondary breast cancer can be difficult, with the relative rarity of the latter representing a diagnostic challenge. Here, we present a case of small cell lung cancer with synchronous bilateral breast metastases in